BG103252A - The use of benzopyranols for the treatment of neurological disorders - Google Patents
The use of benzopyranols for the treatment of neurological disordersInfo
- Publication number
- BG103252A BG103252A BG103252A BG10325299A BG103252A BG 103252 A BG103252 A BG 103252A BG 103252 A BG103252 A BG 103252A BG 10325299 A BG10325299 A BG 10325299A BG 103252 A BG103252 A BG 103252A
- Authority
- BG
- Bulgaria
- Prior art keywords
- treatment
- pains
- benzopyranols
- neurological disorders
- neuralgia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9619492.3A GB9619492D0 (en) | 1996-09-18 | 1996-09-18 | Novel treatment |
PCT/EP1997/005168 WO1998011890A1 (en) | 1996-09-18 | 1997-09-15 | Use of benzopyranols to treat neurological disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
BG103252A true BG103252A (en) | 1999-09-30 |
Family
ID=10800127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG103252A BG103252A (en) | 1996-09-18 | 1999-03-15 | The use of benzopyranols for the treatment of neurological disorders |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP0939630B1 (tr) |
JP (1) | JP2001500520A (tr) |
KR (1) | KR20000036184A (tr) |
CN (1) | CN1230885A (tr) |
AP (1) | AP9901473A0 (tr) |
AR (1) | AR008838A1 (tr) |
AT (1) | ATE270102T1 (tr) |
AU (1) | AU730465B2 (tr) |
BG (1) | BG103252A (tr) |
BR (1) | BR9712030A (tr) |
CA (1) | CA2266681A1 (tr) |
DE (1) | DE69729735T2 (tr) |
DZ (1) | DZ2311A1 (tr) |
EA (1) | EA199900306A1 (tr) |
ES (1) | ES2223075T3 (tr) |
GB (1) | GB9619492D0 (tr) |
HU (1) | HUP9904638A3 (tr) |
ID (2) | ID23175A (tr) |
IL (1) | IL128786A0 (tr) |
MA (1) | MA24321A1 (tr) |
NO (1) | NO991292L (tr) |
NZ (1) | NZ334271A (tr) |
OA (1) | OA10998A (tr) |
PE (1) | PE109898A1 (tr) |
PL (1) | PL332313A1 (tr) |
SK (1) | SK35199A3 (tr) |
TR (1) | TR199900527T2 (tr) |
UY (1) | UY24717A1 (tr) |
WO (1) | WO1998011890A1 (tr) |
ZA (1) | ZA978359B (tr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7119214B2 (en) * | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
US20130281524A1 (en) * | 2008-06-05 | 2013-10-24 | Peter Blower | Novel treatments |
CA2726874A1 (en) * | 2008-06-05 | 2009-12-10 | Minster Research Limited | Novel treatments |
EA025824B1 (ru) | 2009-07-27 | 2017-02-28 | Джилид Сайэнс, Инк. | Конденсированные гетероциклические соединения в качестве модуляторов ионных каналов |
RU2012124838A (ru) * | 2009-12-03 | 2014-01-10 | Проксимэджен ЛТД | Лечение инфекционных заболеваний |
CA2782625A1 (en) * | 2009-12-03 | 2011-06-09 | Proximagen Ltd | Treatment of allodynia and hyperalgesia |
CA2802288C (en) | 2010-07-02 | 2018-08-21 | Gilead Sciences, Inc. | Triazolopyridinone compounds as ion channel modulators |
CA2834164A1 (en) | 2011-05-10 | 2012-11-15 | Gilead Sciences, Inc. | Fused benzoxazinones as ion channel modulators |
TWI549944B (zh) | 2011-07-01 | 2016-09-21 | 吉李德科學股份有限公司 | 作為離子通道調節劑之稠合雜環化合物 |
NO3175985T3 (tr) | 2011-07-01 | 2018-04-28 | ||
CN106397317B (zh) * | 2016-09-26 | 2019-03-22 | 天津师范大学 | 1,2,3,4-四氢喹啉化合物及其合成方法与应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
US5510375A (en) * | 1993-11-19 | 1996-04-23 | Warner-Lambert Company | Coumarin derivatives as protease inhibitors and antiviral agents |
CN1234702C (zh) * | 1994-06-10 | 2006-01-04 | 史密丝克莱恩比彻姆有限公司 | 苯并吡喃类化合物和包含它们的药物组合物 |
GB9411635D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Novel treatment |
-
1996
- 1996-09-18 GB GBGB9619492.3A patent/GB9619492D0/en active Pending
-
1997
- 1997-09-15 SK SK351-99A patent/SK35199A3/sk unknown
- 1997-09-15 JP JP10514309A patent/JP2001500520A/ja not_active Ceased
- 1997-09-15 EP EP97909300A patent/EP0939630B1/en not_active Expired - Lifetime
- 1997-09-15 ES ES97909300T patent/ES2223075T3/es not_active Expired - Lifetime
- 1997-09-15 CN CN97197979A patent/CN1230885A/zh active Pending
- 1997-09-15 PL PL97332313A patent/PL332313A1/xx unknown
- 1997-09-15 AT AT97909300T patent/ATE270102T1/de not_active IP Right Cessation
- 1997-09-15 WO PCT/EP1997/005168 patent/WO1998011890A1/en not_active Application Discontinuation
- 1997-09-15 KR KR1019997002238A patent/KR20000036184A/ko not_active Application Discontinuation
- 1997-09-15 AU AU47047/97A patent/AU730465B2/en not_active Ceased
- 1997-09-15 CA CA002266681A patent/CA2266681A1/en not_active Abandoned
- 1997-09-15 IL IL12878697A patent/IL128786A0/xx unknown
- 1997-09-15 DE DE69729735T patent/DE69729735T2/de not_active Expired - Fee Related
- 1997-09-15 AP APAP/P/1999/001473A patent/AP9901473A0/en unknown
- 1997-09-15 EA EA199900306A patent/EA199900306A1/ru unknown
- 1997-09-15 TR TR1999/00527T patent/TR199900527T2/tr unknown
- 1997-09-15 HU HU9904638A patent/HUP9904638A3/hu unknown
- 1997-09-15 NZ NZ334271A patent/NZ334271A/en unknown
- 1997-09-15 ID IDW990097A patent/ID23175A/id unknown
- 1997-09-15 BR BR9712030A patent/BR9712030A/pt not_active IP Right Cessation
- 1997-09-16 ID IDP973201A patent/ID19542A/id unknown
- 1997-09-16 MA MA24799A patent/MA24321A1/fr unknown
- 1997-09-16 AR ARP970104238A patent/AR008838A1/es not_active Application Discontinuation
- 1997-09-16 UY UY24717A patent/UY24717A1/es not_active Application Discontinuation
- 1997-09-17 DZ DZ970161A patent/DZ2311A1/xx active
- 1997-09-17 ZA ZA978359A patent/ZA978359B/xx unknown
- 1997-09-18 PE PE1997000831A patent/PE109898A1/es not_active Application Discontinuation
-
1999
- 1999-03-15 BG BG103252A patent/BG103252A/xx unknown
- 1999-03-17 NO NO991292A patent/NO991292L/no not_active Application Discontinuation
- 1999-03-18 OA OA9900060A patent/OA10998A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ATE270102T1 (de) | 2004-07-15 |
JP2001500520A (ja) | 2001-01-16 |
DE69729735D1 (de) | 2004-08-05 |
NO991292D0 (no) | 1999-03-17 |
KR20000036184A (ko) | 2000-06-26 |
NO991292L (no) | 1999-03-17 |
ID23175A (id) | 2000-03-23 |
MA24321A1 (fr) | 1998-04-01 |
DE69729735T2 (de) | 2005-07-14 |
AU4704797A (en) | 1998-04-14 |
AR008838A1 (es) | 2000-02-23 |
ID19542A (id) | 1998-07-23 |
ZA978359B (en) | 1999-03-17 |
PE109898A1 (es) | 1999-03-21 |
CA2266681A1 (en) | 1998-03-26 |
UY24717A1 (es) | 2001-08-27 |
TR199900527T2 (tr) | 1999-06-21 |
EP0939630B1 (en) | 2004-06-30 |
AP9901473A0 (en) | 1999-03-31 |
BR9712030A (pt) | 1999-08-24 |
EP0939630A1 (en) | 1999-09-08 |
HUP9904638A3 (en) | 2001-08-28 |
IL128786A0 (en) | 2000-01-31 |
NZ334271A (en) | 2001-03-30 |
WO1998011890A1 (en) | 1998-03-26 |
CN1230885A (zh) | 1999-10-06 |
OA10998A (en) | 2003-03-04 |
DZ2311A1 (fr) | 2002-12-28 |
AU730465B2 (en) | 2001-03-08 |
PL332313A1 (en) | 1999-08-30 |
ES2223075T3 (es) | 2005-02-16 |
EA199900306A1 (ru) | 1999-08-26 |
GB9619492D0 (en) | 1996-10-30 |
HUP9904638A2 (hu) | 2001-05-28 |
SK35199A3 (en) | 2000-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001236904A1 (en) | Deep brain stimulation system for the treatment of parkinson's disease or other disorders | |
EP0792156A4 (en) | METHOD FOR PREVENTING OR TREATING VASCULAR HEMORRAGIES AND ALZHEIMERIC DISEASE | |
EP0467164A3 (en) | Use of the compound flupirtine against muscle bracing | |
AU2001273574A1 (en) | Substituted 5-alkynyl pyrimidines having neurotrophic activity | |
WO1998020864A3 (en) | Use of selected non-steroidal antiinflammatory compounds for the prevention and the treatment of neurodegenerative diseases | |
GB0108592D0 (en) | Therapeutic agents | |
AP2004003069A0 (en) | 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof. | |
WO2001009118A3 (en) | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement | |
FR2706767B1 (tr) | ||
AU2160492A (en) | Treatment of human diseases involving dysregulation or dysfunction of the nervous system | |
BG103252A (en) | The use of benzopyranols for the treatment of neurological disorders | |
IL110943A (en) | Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders | |
MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
ZA977310B (en) | Transdermal propentofylline compositions for the treatment of Alzheimer's disease. | |
AP1749A (en) | Method of treating of demyelinating diseases or conditions. | |
EP1032556A4 (en) | PHARMACEUTICALLY EFFECTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION | |
WO2000021513A3 (en) | Methods for treating multiple sclerosis | |
EP1126850A4 (en) | TREATMENT OF CONDITIONS OF THE RETINA | |
BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
IL130586A0 (en) | IL6RIL6 chimera for the treatment of demyelinating diseases | |
AU634003B2 (en) | 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants | |
BG102079A (en) | Alkylaminoderivatives of substituted quinoxalin-2,3-dions such as glutamatereceptor antagonists | |
WO2003020221A3 (en) | Method of treating cancerous disease | |
ZA985668B (en) | (S)-2-methylamino-2-phenyl-n-butyl 3,4,5-trimethoxy benzoate its application to the treatment of chronic pain | |
NZ268914A (en) | Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease |